| Pharmaceutical active ingredients: |
| Disulfiram |
| Available forms, composition and doses of Alk-Aubs: |
| N / A |
| Alk-Aubs medical category: |
| Human:AntidotesDetoxifying agents and drugs used in substance dependence |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07BB01 - DisulfiramP03AA04 - Disulfiram |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Abstinyl | Disulfiram | Unidentified Pharmaceutical Company |
| Accel Tet | Disulfiram | Unidentified Pharmaceutical Company |
| Accel Tet-R | Disulfiram | Unidentified Pharmaceutical Company |
| Akrochem TETD | Disulfiram | Unidentified Pharmaceutical Company |
| Alcophobin | Disulfiram | Unidentified Pharmaceutical Company |
| Ancazide ET | Disulfiram | Unidentified Pharmaceutical Company |
| Antabus | Disulfiram | Alpharma; Actavis; Bohm; Chemomedica Medizintechnik und Arzneimittel; Farmo Quimica del Pacifico; Inpac Pharma; Nobel Ilac; Team Medica |
| Antabuse | Disulfiram | Wyeth; Actavis; Alpharma; Barr Laboratories; CSL; Delfi Singapore; Dexxon; Neopharm, Israel; Odyssey Pharmaceuticals; Orphan Pharmaceutical; Pharmacare; Sanofi-Aventis; Sirton Pharmaceuticals; Stada |
| Antadix | Disulfiram | Unidentified Pharmaceutical Company |
| Antaenyl | Disulfiram | Sanofi-Aventis |